Sep. 4, 2012 | Allgemein, company news @en, DE
The gesetzlichen Krankenversicherungen (GKV) spent less on drugs in 2011 according to the Arzneimittel-Atlas 2012 – an independent report undertaken by the ´Verband der forschended Arzneimittelhersteller´ (vfa) – commissioned by the ´Institut für...
Sep. 4, 2012 | Allgemein, company news @en, DE, transactions
Health care group Fresenius have decided not to submit any new bid to shareholders of Rhön-Klinikum AG until further notice. By doing so, Fresenius have provided clarity on the matter, to all parties. In recent weeks, Fresenius had been searching for solutions in...
Sep. 3, 2012 | Allgemein, company news @en, DE, transactions
After the decision by the Joint Senate over the removal of prescription discounts, potential buyers are now distancing themselves from any deal with DocMorris. One bidder has already dropped out, and two others have also announced their intention to refrain from any...
Aug. 31, 2012 | Allgemein, company news @en, DE, transactions
After Fresenius´ bid to takeover hospital operator Rhön-Klinikum failed as not all of the 90% of the shareholders supported the deal, the conditions for a second takeover attempt have become considerably cheaper. Apparently, ten representatives on the Supervisory...
Aug. 31, 2012 | Allgemein, company news @en, DE, market knowledge
According to prevailing opinions, the demographic trends of Germany were the biggest cost drivers in the health system. With the number of elderly people increasing, as well as those living for longer, there are enormous costs for the treatment of diseases and...
Aug. 31, 2012 | Allgemein, company news @en, DE, new products
Pharmaceutical and chemical giant Bayer has a new cancer drug in the pipeline, for gastrointestinal tumours (Gist), which continue to grow in spite of standard therapy treatment. In the U.S., it is likely that the rubber-stamped approval will be sought immediately, as...
